The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...
The scientists checked levels of 17 different PFAS compounds and found that some of these chemicals were present at higher ...
Prescription drug costs continue to squeeze Washington businesses and their employees. About 1 in 5 adults in the U.S. said ...
Pharma Dynamics has entered the medical device market following the introduction of South Africa’s first generic ...
While potassium is often celebrated for its role in blood pressure regulation, its benefits extend to numerous aspects of ...
One approach gaining attention is the strategic use of PR links, which many businesses are exploring to strengthen their ...
BridgeBio Pharma, Inc. remains a Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics. Learn more ...
Hosted on MSN
Dr Reddy’s wins early Canada nod for generic Ozempic
Dr Reddy’s Laboratories has received early approval from Health Canada to market its generic semaglutide injection, the first ...
Management emphasized that both revenue and adjusted EBITDA grew for the twelfth consecutive quarter, reflecting operational ...
Morning Overview on MSN
Pfizer settles patent fights, keeping heart drug shielded from generics to 2031
Patients taking Pfizer’s Vyndaqel and Vyndamax for a progressive, often fatal form of heart failure will not see cheaper ...
The expanded MuleSoft investment builds on Asymbl's multi-year Salesforce collaboration, announced in February 2026, focused ...
These Michigan historic villages and living history sites turn the past into something lively, immersive, and surprisingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results